Cell Cycle Checkpoint Defects as Targets for Breast Cancer Therapy: From Bench to Bedside
Surgeons, advanced practice providers, fellows, residents, and medical students in various surgical specialties and subspecialties need to receive regular updates on advances in surgical care and clinical practices. Novel technologies and procedures will be examined as means to improve the diagnosis and treatment of medical conditions requiring surgical intervention. The series aims to expand the knowledge of learners, enhance surgical skills, increase surgical efficiency, disseminate surgical best practices, and improve surgical outcomes.
Physicians, medical students, fellows, and residents.
At the conclusion of the session, the participants should be able to:
Review the addition of biologic markers to anatomic staging of breast cancer.
Discuss biologic markers in developing therapeutic strategies.
Describe how novel therapies have been translated from laboratory findings to clinical trials.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation